Literature DB >> 26361408

Surgical treatment of pancreatic head cancer: concept revolutions and arguments.

Zhe Cao1, Jianwei Xu1, Qianqian Shao1, Taiping Zhang1, Yupei Zhao1.   

Abstract

As we have a deeper and more thorough understanding of the biological behavior of pancreatic head cancer, surgical treatment concepts of this lethal disease are changing all the time. Meanwhile, numerous arguments emerge. Thus, we will probe into the focuses and arguments in the surgical treatment of pancreatic head cancer in this article, including the scope of lymphadenectomy, total mesopancreas excision (TMpE), vascular resection, minimally invasive pancreaticoduodenectomy (PD), palliative resection, surgery for recurrent disease and surgery for primary pancreatic cancer and liver metastasis.

Entities:  

Keywords:  Surgical treatment; pancreatic head cancer

Year:  2015        PMID: 26361408      PMCID: PMC4560738          DOI: 10.3978/j.issn.1000-9604.2015.04.13

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  16 in total

1.  [New classification of pancreatic carcinoma--Japan Pancreas Society].

Authors:  Yoshifumi Kawarada
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2003-08

Review 2.  The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence.

Authors:  Michael B Farnell; Gerard V Aranha; Yuji Nimura; Fabrizio Michelassi
Journal:  J Gastrointest Surg       Date:  2007-12-18       Impact factor: 3.452

3.  Surgery for recurrent pancreatic ductal adenocarcinoma.

Authors:  Jörg Kleeff; Carolin Reiser; Ulf Hinz; Jeannine Bachmann; Jürgen Debus; Dirk Jaeger; Helmut Friess; Markus W Büchler
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

4.  Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Y Kawabata; T Tanaka; T Nishi; H Monma; S Yano; Y Tajima
Journal:  Eur J Surg Oncol       Date:  2012-05-09       Impact factor: 4.424

Review 5.  Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis.

Authors:  Camilo Correa-Gallego; Helen E Dinkelspiel; Isabel Sulimanoff; Sarah Fisher; Eduardo F Viñuela; T Peter Kingham; Yuman Fong; Ronald P DeMatteo; Michael I D'Angelica; William R Jarnagin; Peter J Allen
Journal:  J Am Coll Surg       Date:  2013-11-23       Impact factor: 6.113

Review 6.  Palliative resections versus palliative bypass procedures in pancreatic cancer--a systematic review.

Authors:  Sonja Gillen; Tibor Schuster; Helmut Friess; Jörg Kleeff
Journal:  Am J Surg       Date:  2011-08-26       Impact factor: 2.565

7.  Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study.

Authors:  Reena Ravikumar; Caroline Sabin; Mohammad Abu Hilal; Simon Bramhall; Steven White; Stephen Wigmore; Charles J Imber; Giuseppe Fusai
Journal:  J Am Coll Surg       Date:  2013-11-27       Impact factor: 6.113

Review 8.  Resection of primary pancreatic cancer and liver metastasis: a systematic review.

Authors:  Christoph W Michalski; Mert Erkan; Norbert Hüser; Michael W Müller; Mark Hartel; Helmut Friess; Jörg Kleeff
Journal:  Dig Surg       Date:  2009-02-12       Impact factor: 2.588

9.  Perineural invasion of carcinoma of the pancreas and biliary tract.

Authors:  T Nagakawa; K Mori; T Nakano; M Kadoya; H Kobayashi; T Akiyama; M Kayahara; T Ohta; K Ueno; Y Higashino
Journal:  Br J Surg       Date:  1993-05       Impact factor: 6.939

10.  The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials.

Authors:  J Gaedcke; B Gunawan; M Grade; R Szöke; T Liersch; H Becker; B M Ghadimi
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

View more
  1 in total

1.  Systematic review of the mesopancreas: concept and clinical implications.

Authors:  J M Ramia; R De-la-Plaza; A Manuel-Vazquez; A Lopez-Marcano; R Morales
Journal:  Clin Transl Oncol       Date:  2018-04-19       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.